|
|
||||||||
Department of Physiology, Monash University, Melbourne, Victoria 3800, Australia
| |
ABSTRACT |
|---|
|
|
|---|
Endothelium-derived hyperpolarizing factor (EDHF)-attributed hyperpolarizations and relaxations were recorded simultaneously from submucosal arterioles of guinea pigs with the use of intracellular microelectrodes and a video-based system, respectively. Membrane currents were recorded from electrically short segments of arterioles under single-electrode voltage clamp. Substance P evoked an outward current with a current-voltage relationship that was well described by the Goldman-Hodgkin-Katz equation for a K+ current, consistent with the involvement of intermediate- and small-conductance Ca2+-activated K+ channels. 1-Ethyl-2-benzimidazolinone relaxed the arterioles and evoked hyperpolarizations that were blocked by charybdotoxin, but not by iberiotoxin. Application of K+ induced depolarization under conditions in which EDHF evoked hyperpolarization. The Ba2+-sensitive component of the K+-induced current was inwardly rectifying, in contrast to the outwardly rectifying current evoked by substance P. EDHF-attributed hyperpolarizations in dye-identified smooth muscle cells were indistinguishable from those recorded from dye-identified endothelial cells in the same arterioles. These results provide evidence that EDHF is not K+ but may involve electrotonic spread of hyperpolarization from the endothelial cells to the smooth muscle cells.
calcium-activated potassium current; endothelium; gap junction; voltage clamp; 1-ethyl-2-benzimidazolinone
| |
INTRODUCTION |
|---|
|
|
|---|
DESPITE VARIOUS ATTEMPTS to identify the processes underlying the phenomenon of endothelium-derived hyperpolarizing factor (EDHF), the nature of EDHF remains enigmatic. The main contenders that are the focus of many studies include a product of the cytochrome P-450 pathway (2, 6-8, 14, 19, 21, 23, 32, 34, 39), release of K+ from the endothelial cells (6, 14, 16, 26, 33), and electrotonic spread of hyperpolarization generated in endothelial cells to the underlying smooth muscle (4, 5, 9, 20, 22, 27, 42, 43).
The ultimate identification of EDHF as a chemical entity or some other process requires a detailed knowledge of its mechanisms of action, including the ionic mechanisms underlying the hyperpolarization. To this end, we recently used the single-electrode voltage-clamp technique to describe the ionic currents that underlie the EDHF-attributed hyperpolarization evoked by ACh in submucosal arterioles of the guinea pig (10). The current had characteristics consistent with the involvement of Ca2+-activated K+ (KCa) channels of intermediate and small conductance (IKCa and SKCa channels, respectively) (10). The presence of IKCa channels in blood vessels has been suggested by the effects of 1-ethyl-2-benzimidazolinone (1-EBIO), an activator of IKCa channels, which has been shown to relax (1, 38) and hyperpolarize (17, 18) some vessels. In the present study, we tested the effect of 1-EBIO on membrane potential in dye-identified endothelial and smooth muscle cells to gain further evidence of IKCa channels in these arterioles and to provide information as to the site of generation of EDHF.
The likelihood of electrical coupling between the endothelial and smooth muscle cells of at least some blood vessels (4, 9, 20, 27, 28, 35, 41), including submucosal arterioles (10, 11), invites additional study, since it could explain EDHF. Definitive evidence of this mechanism could be provided by agents that disrupt electrical conductance of gap junctions. Unfortunately, the putative gap junction inhibitors based on glycyrrhetinic acid and its derivatives do not appear to uncouple the cells electrically to any great extent, but they possess a range of nonspecific effects that severely limit their usefulness in the assessment of the role of gap junctions in mediating the EDHF-attributed hyperpolarization (10, 37). In the present study, we provide evidence that the EDHF-attributed hyperpolarization is not due to K+, but recordings made from dye-identified smooth muscle and endothelial cells in the same segments of arteriole are consistent with electrotonic spread of current from the endothelial cells to the smooth muscle cells in arterioles.
| |
METHODS |
|---|
|
|
|---|
Guinea pigs were killed by cervical dislocation and
exsanguination with approval of the Monash University Animal Ethics
Committees. A section of the small intestine was removed from each
animal, the muscle and mucosal layers were peeled away, and the thin
sheet of connective tissue containing the submucosal arterioles was pinned to the floor of the recording chamber (10). The
tissue was continuously superfused at 3 ml/min and 35°C with
physiological saline solution consisting of (in mM) 120 NaCl, 5 KCl, 25 NaHCO3, 1 KH2PO4, 1.2 MgSO4, 2.5 CaCl2, and 11 glucose and bubbled
with 95% O2-5% CO2.
N
-nitro-L-arginine methyl ester
(L-NAME, 100 µM) and indomethacin (1 µM) were included
in the superfusate to inhibit nitric oxide and prostanoid production,
respectively. All responses to endothelial stimulation with ACh or
substance P are therefore attributed to EDHF.
Arterioles (20-50 µm OD) were studied by recording membrane potential with intracellular microelectrodes simultaneously with contractile activity recorded as diameter by computer-based analysis of video images (Diamtrak) (30). The cells from which the recordings were made were identified by loading the cells with the fluorescent dye Lucifer yellow (2%), which was included in the tips of the microelectrodes (10). In some experiments, the arterioles were cut into electrically short segments, and membrane currents were recorded with single intracellular microelectrodes under voltage-clamp mode using a switching amplifier (AxoClamp-2, Axon Instruments) (10). Membrane currents were normalized to the input capacitance of the arteriole segment. Periodic voltage ramp commands, generated with pClamp 6 software (Axon Instruments), were used to determine current-voltage relationships. Responses to voltage ramps recorded before drug application were subtracted from the ramp responses recorded during drug application to determine the current-voltage relationships of the current activated or inhibited by the drug.
ACh, substance P, L-NAME, indomethacin, ouabain, iberiotoxin (IbTx), and dilithium Lucifer yellow CH were obtained from Sigma Chemical, and 1-EBIO was obtained from Tocris Cookson. Charybdotoxin (ChTx) was synthesized by Auspep (Australia).
Data were compared using Student's t-test and the software package InStat 3 (GraphPad). Values are means ± SE; n refers to the number of animals. P < 0.05 were considered statistically significant.
| |
RESULTS |
|---|
|
|
|---|
The EDHF-attributed hyperpolarizations recorded from
dye-identified smooth muscle cells were indistinguishable from the
hyperpolarizations evoked by ACh in dye-identified endothelial cells in
the same section of arteriole (n = 3). This is
illustrated in Fig. 1, in which the
membrane had been depolarized using a low concentration of
Ba2+ to partially block the inwardly rectifying
K+ (KIR) channel. With the very large resting
membrane potentials of both cell types in these tissues, the
EDHF-attributed hyperpolarization was small (~2 mV) in the absence of
Ba2+ (10).
|
In the presence of L-NAME and indomethacin, substance P (1 µM) evoked hyperpolarization of the arterioles (n = 6). Under voltage-clamp condition, it evoked an outward current that
inactivated during the continued presence of substance P (Fig.
2A; n = 3).
The current activated by substance P, and attributed to EDHF, reversed
at
77 ± 5 mV (n = 3), which is not different
from the likely K+ equilibrium potential of
85 mV
(P = 0.27), was outwardly rectifying, and was well
described by the Goldman-Hodgkin-Katz equation for a K+
current (Fig. 2B). The hyperpolarization evoked by substance P was blocked by the combined presence of 30 nM ChTx + 0.25 µM apamin (n = 3).
|
The presence of IKCa channels in the submucosal arterioles
was tested by applying an activator of these channels, 1-EBIO. 1-EBIO
evoked hyperpolarization in 11 of 12 dye-identified endothelial cells,
and hyperpolarizations of similar amplitudes were recorded in 3 of 3 dye-identified smooth muscle cells. Figure
3A shows that 1-EBIO (600 µM) evoked hyperpolarization that was insensitive to IbTx (45 nM) but
was blocked by ChTx (40 nM, n = 3), properties that
indicate that IKCa, but not SKCa or
large-conductance Ca2+-activated K+
(BKCa), channels were activated by 1-EBIO. The functional
significance of 1-EBIO in terms of evoking relaxation of the arterioles
is demonstrated in Fig. 3B (n = 8).
|
It has been reported that the EDHF-attributed hyperpolarization in rat
hepatic arteries is due to the release of K+ from the
endothelial cells, since the EDHF-attributed hyperpolarization could be
blocked by a combination of Ba2+ and ouabain
(16). This possibility was assessed in submucosal arterioles by comparing the effect of ACh with the effect of 5 mM KCl
in solutions containing normal physiological saline solution, ouabain,
and ouabain + Ba2+. As shown in Fig.
4A, ACh evoked
hyperpolarization under conditions in which KCl evoked depolarization.
In the presence of ouabain and ouabain + Ba2+, ACh
still evoked substantial hyperpolarization that was associated with
relaxation of the arteriole (Fig. 4A). The currents
activated by the addition of 5 mM KCl were recorded under the
voltage-clamp condition, and the Ba2+-sensitive component
is shown in Fig. 4Bd. Of the total current resulting from
the application of K+, 87.1 ± 7.8%
(n = 3, at a membrane potential of
80 mV) was
sensitive to blockade by Ba2+. This current was inwardly
rectifying, typical of KIR channels (Fig. 4Bb),
and thus had a shape different from that of the outwardly rectifying
current activated by substance P and attributed to EDHF (Fig. 2).
Furthermore, the Ba2+-sensitive current activated by raised
K+ reversed at a membrane potential appreciably more
positive than the EDHF current activated by substance P (cf. Figs.
4Bd and 2B).
|
| |
DISCUSSION |
|---|
|
|
|---|
The results of this study show that substance P activates an EDHF-attributed K+ current that is well described by the Goldman-Hodgkin-Katz equation and, therefore, displays little, if any, voltage-dependent channel gating. This property is consistent with the activity of IKCa and SKCa channels and with the recent detailed study of the currents activated by ACh and attributed to EDHF in these arterioles (10). We have gone on to show that 1-EBIO can also evoke hyperpolarization in these arterioles. Although 1-EBIO is considered to be an activator of IKCa channels (13), the effects of this drug need to be interpreted with some caution, since there are indications that it can have other effects (12, 13, 36). Nevertheless, in the present study, the hyperpolarization evoked by 1-EBIO was blocked by ChTx but not by IbTx, and this is good evidence that it was activating IKCa channels in these arterioles.
Although ChTx abolished the hyperpolarization due to 1-EBIO, it did not abolish the hyperpolarization evoked by ACh. We previously showed that the outward current evoked by ACh is reduced by ChTx but requires ChTx combined with apamin to abolish the outward current (10). Thus, whereas the actions of 1-EBIO are consistent with its activation of IKCa channels, ACh is likely to additionally activate SKCa channels, which are blocked by apamin.
The location of the K+ channels underlying the EDHF hyperpolarization is a fundamental question. We now show that the EDHF-attributed hyperpolarization recorded from dye-identified smooth muscle cells is indistinguishable from the response recorded from dye-identified endothelial cells in the same segment of arteriole. This, together with our previous work showing that the endothelial and smooth muscle cells are tightly coupled electrically (10), suggests that the two layers function as a single electrical syncytium, in general agreement with other results (43) including a mathematical model of coupling in these arterioles (11), as well as the results obtained from some other blood vessels (4, 9, 20, 27, 28, 35, 41). Furthermore, 1-EBIO evoked IKCa-dependent hyperpolarizations in the endothelial and smooth muscle cells. IKCa channels occur in tissues rich in epithelia (24), including endothelial cells (25, 29, 40), but there is little, if any, evidence for their presence in noncultured vascular smooth muscle cells. Consistent with an endothelial location of IKCa channels, 1-EBIO activated a current with IKCa-like properties in cultured endothelial cells but not in isolated smooth muscle cells of the rat hepatic artery (18). Our observations are therefore consistent with the EDHF-attributed hyperpolarization involving the activation of IKCa channels in the endothelial cells and the current then spreading with negligible attenuation via myoendothelial gap junctions to the smooth muscle cells. In addition, sensitivity of a component of the EDHF current to block by apamin indicates that SKCa channels are also involved in the EDHF-attributed hyperpolarization of submucosal arterioles (10).
An alternative explanation for our observations is that EDHF may be a diffusible factor that hyperpolarizes the smooth muscle and that hyperpolarization could then spread electrotonically to the endothelial cells. One way to resolve the issue would be to inhibit the myoendothelial gap junctions. Although glycyrrhetinic acid and its derivatives have been used to inhibit gap junctions, these triterpenoid saponins have a number of effects in these arterioles, as well as in larger blood vessels, that include the inhibition of action potentials, inhibition of hyperpolarization in identified endothelial cells, and considerable depolarization (10, 37). Thus the nonspecific effects of glycyrrhetinic acid and its derivatives preclude the usefulness of these compounds in determining the role of gap junction communication in the actions of EDHF, similar to other putative gap junction inhibitors. Peptides based on the extracellular structure of connexins may provide a means of inhibiting gap junction communication. However, putative peptide gap junction inhibitors such as Gap 27 have not been shown to inhibit current flow through gap junctions. Inhibition of dye coupling is not necessarily a good indicator of inhibition of electrical coupling, since we observe good electrical coupling between endothelial and smooth muscle cells in the absence of dye coupling (Fig. 1).
The possible involvement of K+ as EDHF was explored further
in this study. The application of additional K+ resulted in
depolarization, in contrast to the hyperpolarization evoked by ACh
under similar conditions. Furthermore, the hyperpolarization evoked by
ACh was not inhibited by ouabain with or without low concentrations of
Ba2+, providing further evidence that EDHF does not involve
activation of the Na+-K+ pump and/or
KIR channels, in agreement with the effects of added K+ recorded under voltage-clamp condition from short
segments of these arterioles (10). This is despite the
observations that the addition of K+ was capable of
activating KIR channels and that these channels carried the
majority of the K+-induced current. The
Ba2+-sensitive component of the current activated by raised
K+ was inwardly rectifying, in contrast to the outwardly
rectifying current attributed to EDHF (Fig. 2B). The more
positive reversal potential reflects the new K+ equilibrium
potential in raised extracellular K+. Thus the
EDHF-attributed hyperpolarization does not involve the activation of
KIR channels. The ouabain-sensitive current in these
arterioles has a relatively flat current-voltage relationship with a
likely reversal potential of around
134 mV (10), which is also very different from the current-voltage relationship of the
EDHF-attributed current; this means that the
Na+-K+ pump is not involved in the
EDHF-attributed hyperpolarization.
Apart from K+, metabolites of arachidonic acid catalyzed by cytochrome P-450 have been suggested to be EDHF(s) and have, therefore, been the focus of many studies (see the introduction). We are not aware of any reports of these agents activating IKCa or SKCa channels, but epoxyeicosatrienoic acids, which are products of the cytochrome P-450 pathway, have been reported to activate BKCa channels (3, 15, 19, 44). These observations do not necessarily exclude the involvement of the cytochrome P-450 pathway in the production of EDHF(s), since the actions of these metabolites have not been thoroughly worked out. Furthermore, because BKCa, IKCa, and SKCa channels are activated by raised cytoplasmic free Ca2+, heterogeneity in the distributions of these channels between different blood vessels could result in some differences in the channels that underlie the EDHF-attributed hyperpolarization.
In conclusion, the results presented here are consistent with the idea that the EDHF-attributed hyperpolarization results from the activation of IKCa and SKCa channels and not from the activation of KIR channels or the Na+-K+ pump (10). Endothelial cells in the aortic valve, and therefore not in contact with smooth muscle cells, respond to stimulation with ACh by hyperpolarizing (31) with a time course that is strikingly similar to that recorded from submucosal arterioles (this study), which is consistent with the generation of EDHF in the endothelial cells. Thus, although there is still no definitive evidence, the most likely explanation for EDHF is that the EDHF-attributed hyperpolarization of these arterioles involves electrotonic spread of hyperpolarizing current from the endothelial cells, via myoendothelial gap junctions, to the smooth muscle cells.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by the National Health and Medical Research Council of Australia and the National Heart Foundation of Australia.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: H. A. Coleman, Dept. of Physiology, PO Box 13F, Monash University, Victoria 3800, Australia (E-mail: h.coleman{at}med.monash.edu.au).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 5 December 2000; accepted in final form 6 February 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adeagbo, ASO
1-Ethyl-2-benzimidazolinone stimulates endothelial KCa channels and nitric oxide formation in rat mesenteric vessels.
Eur J Pharmacol
379:
151-159,
1999[ISI][Medline].
2.
Adeagbo, ASO,
and
Henzel MK.
Calcium-dependent phospholipase A2 mediates the production of endothelium-derived hyperpolarizing factor in perfused rat mesenteric prearteriolar bed.
J Vasc Res
35:
27-35,
1998[ISI][Medline].
3.
Baron, A,
Frieden M,
and
Bény J-L.
Epoxyeicosatrienoic acids activate a high-conductance, Ca2+-dependent K+ channel on pig coronary artery endothelial cells.
J Physiol (Lond)
504:
537-543,
1997[ISI][Medline].
4.
Bény, J-L.
Electrical coupling between smooth muscle cells and endothelial cells in pig coronary arteries.
Pflügers Arch
433:
364-367,
1997[ISI][Medline].
5.
Bény, J-L,
Zhu P,
and
Haefliger IO.
Lack of bradykinin-induced smooth muscle cell hyperpolarization despite heterocellular dye coupling and endothelial cell hyperpolarization in porcine ciliary artery.
J Vasc Res
34:
344-350,
1997[ISI][Medline].
6.
Buus, NH,
Simonsen U,
Pilegaard HK,
and
Mulvany MJ.
Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries.
Br J Pharmacol
129:
184-192,
2000[ISI][Medline].
7.
Campbell, WB,
Gebremedhin D,
Pratt PF,
and
Harder DR.
Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.
Circ Res
78:
415-423,
1996
8.
Campbell, WB,
and
Harder DR.
Endothelium-derived hyperpolarizing factors and vascular cytochrome P-450 metabolites of arachidonic acid in the regulation of tone.
Circ Res
84:
484-488,
1999
9.
Chaytor, AT,
Evans WH,
and
Griffith TM.
Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries.
J Physiol (Lond)
508:
561-573,
1998
10.
Coleman, HA,
Tare M,
and
Parkington HC.
K+ currents underlying the action of endothelium-derived hyperpolarizing factor in guinea-pig, rat and human blood vessels.
J Physiol (Lond)
531:
359-373,
2001
11.
Crane, GJ,
Kotecha N,
and
Neild TO.
Electrical connection between the endothelium and the smooth muscle in guinea-pig intestinal submucosal arterioles.
Prog Microcirc Res
10:
54-56,
1999.
12.
Cuthbert, AW,
Hickman ME,
Thorn P,
and
MacVinish LJ.
Activation of Ca2+- and cAMP-sensitive K+ channels in murine colonic epithelia by 1-ethyl-2-benzimidazolone.
Am J Physiol Cell Physiol
277:
C111-C120,
1999
13.
Devor, DC,
Singh AK,
Bridges RJ,
and
Frizzell RA.
Modulation of Cl
secretion by benzimidazolones. II. Coordinate regulation of apical GCl and basolateral GK.
Am J Physiol Lung Cell Mol Physiol
271:
L785-L795,
1996
14.
Drummond, GR,
Selemidis S,
and
Cocks TM.
Apamin-sensitive, non-nitric oxide (NO) endothelium-dependent relaxations to bradykinin in the bovine isolated coronary artery: no role for cytochrome P450 and K+.
Br J Pharmacol
129:
811-819,
2000[ISI][Medline].
15.
Eckman, DM,
Hopkins N,
McBride C,
and
Keef KD.
Endothelium-dependent relaxation and hyperpolarization in guinea-pig coronary artery: role of epoxyeicosatrienoic acid.
Br J Pharmacol
124:
181-189,
1998[ISI][Medline].
16.
Edwards, G,
Dora KA,
Gardener MJ,
Garland CJ,
and
Weston AH.
K+ is an endothelium-derived hyperpolarizing factor in rat arteries.
Nature
396:
269-272,
1998[Medline].
17.
Edwards, G,
Félétou M,
Gardener MJ,
Thollon C,
Vanhoutte PM,
and
Weston AH.
Role of gap junctions in the responses to EDHF in rat and guinea-pig small arteries.
Br J Pharmacol
128:
1788-1794,
1999[ISI][Medline].
18.
Edwards, G,
Gardener MJ,
Félétou M,
Brady G,
Vanhoutte PM,
and
Weston AH.
Further investigation of endothelium-derived hyperpolarizing factor (EDHF) in rat hepatic artery: studies using 1-EBIO and ouabain.
Br J Pharmacol
128:
1064-1070,
1999[ISI][Medline].
19.
Edwards, G,
Thollon C,
Gardener MJ,
Félétou M,
Vilaine JP,
Vanhoutte PM,
and
Weston AH.
Role of gap junctions and EETs in endothelium-dependent hyperpolarization of porcine coronary artery.
Br J Pharmacol
129:
1145-1154,
2000[ISI][Medline].
20.
Emerson, GG,
and
Segal SS.
Electrical coupling between endothelial cells and smooth muscle cells in hamster feed arteries
role in vasomotor control.
Circ Res
87:
474-479,
2000
21.
Fisslthaler, B,
Popp R,
Kiss L,
Potente M,
Harder DR,
Fleming I,
and
Busse R.
Cytochrome P-450 2C is an EDHF synthase in coronary arteries.
Nature
401:
493-497,
1999[Medline].
22.
Garland, CJ,
Plane F,
Kemp BK,
and
Cocks TM.
Endothelium-dependent hyperpolarization: a role in the control of vascular tone.
Trends Pharmacol Sci
16:
23-30,
1995[Medline].
23.
Hecker, M,
Bara AT,
Bauersachs J,
and
Busse R.
Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P-450-derived arachidonic acid metabolite in mammals.
J Physiol (Lond)
481:
407-414,
1994[ISI][Medline].
24.
Jensen, BS,
Strøbæk D,
Christophersen P,
Jørgensen TD,
Hansen C,
Silahtaroglu A,
Olesen SP,
and
Ahring PK.
Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel.
Am J Physiol Cell Physiol
275:
C848-C856,
1998
25.
Köhler, R,
Degenhardt C,
Kühn M,
Runkel N,
Paul M,
and
Hoyer J.
Expression and function of endothelial Ca2+-activated K+ channels in human mesenteric artery
a single-cell reverse transcriptase-polymerase chain reaction and electrophysiological study in situ.
Circ Res
87:
496-503,
2000
26.
Lacy, PS,
Pilkington G,
Hanvesakul R,
Fish HJ,
Boyle JP,
and
Thurston H.
Evidence against potassium as an endothelium-derived hyperpolarizing factor in rat mesenteric small arteries.
Br J Pharmacol
129:
605-611,
2000[ISI][Medline].
27.
Little, TL,
Xia J,
and
Duling BR.
Dye tracers define differential endothelial and smooth muscle coupling patterns within the arteriolar wall.
Circ Res
76:
498-504,
1995
28.
Marchenko, SM,
and
Sage SO.
Smooth muscle cells affect endothelial membrane potential in rat aorta.
Am J Physiol Heart Circ Physiol
267:
H804-H811,
1994
29.
Marchenko, SM,
and
Sage SO.
Calcium-activated potassium channels in the endothelium of intact rat aorta.
J Physiol (Lond)
492:
53-60,
1996[ISI][Medline].
30.
Neild, TO.
Measurement of arteriole diameter changes by analysis of television images.
Blood Vessels
26:
48-52,
1989[ISI][Medline].
31.
Ohashi, M,
Satoh K,
and
Itoh T.
Acetylcholine-induced membrane potential changes in endothelial cells of rabbit aortic valve.
Br J Pharmacol
126:
19-26,
1999[ISI][Medline].
32.
Petersson, J,
Zygmunt PM,
Jönsson P,
and
Högestätt ED.
Characterization of endothelium-dependent relaxation in guinea pig basilar artery
effect of hypoxia and role of cytochrome P450 mono-oxygenase.
J Vasc Res
35:
285-294,
1998[ISI][Medline].
33.
Quignard, JF,
Félétou M,
Thollon C,
Vilaine JP,
Duhault J,
and
Vanhoutte PM.
Potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig carotid and porcine coronary arteries.
Br J Pharmacol
127:
27-34,
1999[ISI][Medline].
34.
Quilley, J,
and
McGiff JC.
Is EDHF an epoxyeicosatrienoic acid?
Trends Pharmacol Sci
21:
121-124,
2000[Medline].
35.
Sandow, SL,
and
Hill CE.
Incidence of myoendothelial gap junctions in the proximal and distal mesenteric arteries of the rat is suggestive of a role in endothelium-derived hyperpolarizing factor-mediated responses.
Circ Res
86:
341-346,
2000
36.
Syme, CA,
Gerlach AC,
Singh AK,
and
Devor DC.
Pharmacological activation of cloned intermediate- and small-conductance Ca2+-activated K+ channels.
Am J Physiol Cell Physiol
278:
C570-C581,
2000
37.
Tare, M,
Coleman HA,
and
Parkington HC.
The actions of glycyrrhetinic acid derivatives on hyperpolarization of identified endothelial cells in arteries (Abstract).
Proc Aust Physiol Pharmacol Soc
31:
68P,
2000.
38.
Van de Voorde, J,
and
Vanheel B.
EDHF-mediated relaxation in rat gastric small arteries: influence of ouabain/Ba2+ and relation to potassium ions.
J Cardiovasc Pharmacol
35:
543-548,
2000[ISI][Medline].
39.
Vanheel, B,
and
Van de Voorde J.
Evidence against the involvement of cytochrome P-450 metabolites in endothelium-dependent hyperpolarization of the rat main mesenteric artery.
J Physiol (Lond)
501:
331-341,
1997[ISI][Medline].
40.
Van Renterghem, C,
Vigne P,
and
Frelin C.
A charybdotoxin-sensitive, Ca2+-activated K+ channel with inward rectifying properties in brain microvascular endothelial cells: properties and activation by endothelins.
J Neurochem
65:
1274-1281,
1995[ISI][Medline].
41.
Von der Weid, P-Y,
and
Bény J-L.
Simultaneous oscillations in the membrane potential of pig coronary artery endothelial and smooth muscle cells.
J Physiol (Lond)
471:
13-24,
1993
42.
Welsh, DG,
and
Segal SS.
Endothelial and smooth muscle cell conduction in arterioles controlling blood flow.
Am J Physiol Heart Circ Physiol
274:
H178-H186,
1998
43.
Yamamoto, Y,
Imaeda K,
and
Suzuki H.
Endothelium-dependent hyperpolarization and intercellular electrical coupling in guinea-pig mesenteric arterioles.
J Physiol (Lond)
514:
505-513,
1999
44.
Zou, A,
Fleming JT,
Falck JR,
Jacobs ER,
Gebremedhin D,
Harder DR,
and
Roman RJ.
Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K+-channel activity.
Am J Physiol Renal Fluid Electrolyte Physiol
270:
F822-F832,
1996
This article has been cited by other articles:
![]() |
P. A. Dabisch, J. T. Liles, S. R. Baber, N. H. Golwala, S. N. Murthy, and P. J. Kadowitz Analysis of L-NAME-dependent and -resistant responses to acetylcholine in the rat Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H688 - H698. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Samora, J. C. Frisbee, and M. A. Boegehold Growth-dependent changes in endothelial factors regulating arteriolar tone Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H207 - H214. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Matchkov, A. Rahman, L. M. Bakker, T. M. Griffith, H. Nilsson, and C. Aalkjaer Analysis of effects of connexin-mimetic peptides in rat mesenteric small arteries Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H357 - H367. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Sokoya, A. R. Burns, C. T. Setiawan, H. A. Coleman, H. C. Parkington, and M. Tare Evidence for the involvement of myoendothelial gap junctions in EDHF-mediated relaxation in the rat middle cerebral artery Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H385 - H393. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Haddy, P. M. Vanhoutte, and M. Feletou Role of potassium in regulating blood flow and blood pressure Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R546 - R552. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Siegl, M. Koeppen, S. E. Wolfle, U. Pohl, and C. de Wit Myoendothelial Coupling Is Not Prominent in Arterioles Within the Mouse Cremaster Microcirculation In Vivo Circ. Res., October 14, 2005; 97(8): 781 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-G. Jiang, A. L Nuttall, H. Zhao, C.-F. Dai, B.-C. Guan, J.-Q. Si, and Y.-Q. Yang Electrical coupling and release of K+ from endothelial cells co-mediate ACh-induced smooth muscle hyperpolarization in guinea-pig inner ear artery J. Physiol., April 15, 2005; 564(2): 475 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Huang, D. Sun, A. Jacobson, M. A. Carroll, J. R. Falck, and G. Kaley Epoxyeicosatrienoic Acids Are Released to Mediate Shear Stress-Dependent Hyperpolarization of Arteriolar Smooth Muscle Circ. Res., February 18, 2005; 96(3): 376 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Earley, T. C. Resta, and B. R. Walker Disruption of smooth muscle gap junctions attenuates myogenic vasoconstriction of mesenteric resistance arteries Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2677 - H2686. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ungvari, A. Csiszar, and A. Koller Increases in endothelial Ca2+ activate KCa channels and elicit EDHF-type arteriolar dilation via gap junctions Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1760 - H1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tare, H. A. Coleman, and H. C. Parkington Glycyrrhetinic derivatives inhibit hyperpolarization in endothelial cells of guinea pig and rat arteries Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H335 - H341. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Campbell and D. R. Harder Prologue: EDHF-what is it? Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2413 - H2416. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |